What’s Happening with $ATHE (Alterity Therapeutics) Today

This morning, on, $ATHE experienced significantly high search volume. What happened?

The surge came as Alterity Therapeutics announced positive data from an animal testing of ATH434, a leading drug candidate for Multiple System Atrophy, a degenerative neurological disorder.

The new data “independently confirm and extend previous findings demonstrating that ATH434 reduces α-synuclein pathology, preserves neurons, and improves motor performance,” Alterity Therapeutics noted.

As of this morning, $ATHE is up 174%.

If you want to be included emailed a list of stocks trending on the internet every day, sign up for Goodseed. You get a daily email of stocks that are exploding on the internet as well as access to the on-demand search volume tool where you can research any stock you’d like. You can even get 10 days for free.

Leave a Reply

Your email address will not be published. Required fields are marked *